title: Characterization of low-affinity binding sites for glibenclamide on the Kir6.2 subunit of the beta-cell KATP channel.
abstract: The ATP-sensitive K+ channel, an octameric complex of two structurally unrelated types of subunits, SUR1 and Kir6.2, plays a central role in the physiological regulation of insulin secretion. The sulfonylurea glibenclamide, which trigger insulin secretion by blocking the ATP-sensitive K+ channel, interacts with both high and low affinity binding sites present on beta-cells. The high affinity binding site has been localized on SUR1 but the molecular nature of the low affinity site is still uncertain. In this study, we analyzed the pharmacology of glibenclamide in a transformed COS-7 cell line expressing the rat Kir6.2 cDNA and compared with that of the MIN6 beta cell line expressing natively both the Kir6.2 and the SUR1 subunits. Binding studies and Scatchard analysis revealed the presence of a single class of low affinity binding sites for glibenclamide on the COS/Kir6.2 cells with characteristics similar to that observed for the low affinity site of the MIN6 beta cells.
authors: INSERM U376, CHU Arnaud-de-Villeneuve, 371 rue du Doyen Gaston Giraud, Montpellier Cedex 5, 34295, France. lgros@u376.montp.insem.fr
authors: L
authors: L
authors: Gros
authors: A
authors: A
authors: Virsolvy
authors: G
authors: G
authors: Salazar
authors: D
authors: D
authors: Bataille
authors: P
authors: P
authors: Blache
mesh_terms: D018528:ATP-Binding Cassette Transporters; D000818:Animals; D001665:Binding Sites; D015152:Blotting, Northern; D019556:COS Cells; D002460:Cell Line; D002462:Cell Membrane / Q000187:drug effects / Q000378:metabolism; D005907:Gliclazide / Q000378:metabolism; D005913:Glipizide / Q000378:metabolism; D005905:Glyburide / Q000378:metabolism* / Q000494:pharmacology; D007515:Islets of Langerhans / Q000166:cytology / Q000378:metabolism*; D007700:Kinetics; D015388:Organelles / Q000378:metabolism; D010646:Phentolamine / Q000378:metabolism; D015221:Potassium Channels / Q000235:genetics / Q000378:metabolism*; D024661:Potassium Channels, Inwardly Rectifying; D051381:Rats; D011955:Receptors, Drug / Q000235:genetics / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D013453:Sulfonylurea Compounds / Q000378:metabolism; D064233:Sulfonylurea Receptors; D014044:Tolbutamide / Q000378:metabolism; D014162:Transfection
chemical_list: D018528:ATP-Binding Cassette Transporters; C577509:Abcc8 protein, rat; D015221:Potassium Channels; D024661:Potassium Channels, Inwardly Rectifying; D011955:Receptors, Drug; D011993:Recombinant Fusion Proteins; D013453:Sulfonylurea Compounds; D064233:Sulfonylurea Receptors; C073323:glibornuride; D014044:Tolbutamide; C010969:gliquidone; D005907:Gliclazide; D005905:Glyburide; D005913:Glipizide; D010646:Phentolamine